大和:降百威(1876.HK)目標至26.3港元 料首季收入受打擊
大和發表研究報告指,百威亞太(1876.HK)由於銷量下跌,去年全年及第四季度EBITDA分別按年增長11%及下跌4%,料今年第一季收武漢爆發的新型冠狀病毒影響,今年首季的收入或受沉重打擊。該行重申其“優於大市”投資評級,目標價由31港元下調至26.3港元。
大和表示,疫情對百威亞太上半年運營及重建市場份額的成本造成影響,故把2020-21年度的收入削減4%,而每股盈利預測則下調12-15%,並預計在下半年反彈前,首季的EBITDA利潤率將按年下跌4-5個百分點。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.